User profiles for M. Garnett

Mathew Garnett

Wellcome Sanger Institute
Verified email at sanger.ac.uk
Cited by 38862

[HTML][HTML] High-content CRISPR screening

…, B Song, G Stanley, S Chen, M Garnett… - Nature Reviews …, 2022 - nature.com
CRISPR screens are a powerful source of biological discovery, enabling the unbiased
interrogation of gene function in a wide range of applications and species. In pooled CRISPR …

[PDF][PDF] Guilty as charged: B-RAF is a human oncogene

MJ Garnett, R Marais - Cancer cell, 2004 - cell.com
RAF proteins are components of a conserved signaling pathway that regulates cellular
responses to extracellular signals. Despite over 20 years of research into the regulation and …

Pediatric craniopharyngiomas: classification and treatment according to the degree of hypothalamic involvement

S Puget, M Garnett, A Wray, J Grill, JL Habrand… - Journal of …, 2007 - thejns.org
Object The current treatment of craniopharyngiomas is evolving into one of a multimodal
approach in which the aim is disease control and improved preservation of quality of life (QOL). …

Systematic identification of genomic markers of drug sensitivity in cancer cells

MJ Garnett, EJ Edelman, SJ Heidorn, CD Greenman… - Nature, 2012 - nature.com
Clinical responses to anticancer therapies are often restricted to a subset of patients. In some
cases, mutated cancer genes are potent biomarkers for responses to targeted agents. Here…

Mutations of the BRAF gene in human cancer

…, S Edkins, S Clegg, J Teague, H Woffendin, MJ Garnett… - Nature, 2002 - nature.com
Cancers arise owing to the accumulation of mutations in critical genes that alter normal
programmes of cell proliferation, differentiation and death. As the first stage of a systematic …

[HTML][HTML] Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-RAF

PTC Wan, MJ Garnett, SM Roe, S Lee… - Cell, 2004 - cell.com
Over 30 mutations of the B-RAF gene associated with human cancers have been identified,
the majority of which are located within the kinase domain. Here we show that of 22 B-RAF …

Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells

…, C Benes, U McDermott, MJ Garnett - Nucleic acids …, 2012 - academic.oup.com
Alterations in cancer genomes strongly influence clinical responses to treatment and in many
instances are potent biomarkers for response to drugs. The Genomics of Drug Sensitivity in …

[HTML][HTML] Prospective derivation of a living organoid biobank of colorectal cancer patients

…, MR Stratton, U McDermott, M Meyerson, MJ Garnett… - Cell, 2015 - cell.com
In Rspondin-based 3D cultures, Lgr5 stem cells from multiple organs form ever-expanding
epithelial organoids that retain their tissue identity. We report the establishment of tumor …

[PDF][PDF] A landscape of pharmacogenomic interactions in cancer

…, J Saez-Rodriguez, U McDermott, MJ Garnett - Cell, 2016 - cell.com
… [Tables S3B and S3C]) yielded four classes referred to as M, H, CD, and CA (Table S3D;
Supplemental Experimental Procedures). Class M is enriched for CG mutations, class H for …

Human primary liver cancer–derived organoid cultures for disease modeling and drug screening

…, MJ Garnett, LJW Van Der Laan, M Huch - Nature medicine, 2017 - nature.com
Human liver cancer research currently lacks in vitro models that can faithfully recapitulate
the pathophysiology of the original tumor. We recently described a novel, near-physiological …